Cliff Ledger Research & Insights Hub

Every empirical study below is generated deterministically from Cliff Ledger publication c7aa149ae887ad06ebb0, uniting 22,438 FDA Orange Book patent rows, Drugs@FDA regulatory histories, deduplicated CMS Part D plus Medicaid reimbursement ($399.94B), and California HCAI SB 17 Wholesale Acquisition Cost and specialty drug launch disclosures.

5,728 Prescription Drugs $399.94B Clean 2024 CMS Spend 17 Official .gov & .ca.gov Feeds Updated 2026-11-18
Pharmaceutical IP & Public Payer Study 01

The 2026 to 2030 Pharmaceutical Patent Cliff: Reconciled FDA Orange Book LOE Windows and Medicare Part D plus Medicaid Exposure

Molecule-by-molecule audit of 91 blockbuster NDAs ($111.06B CMS spend) losing core FDA Orange Book patent protection between 2025 and 2030.

91 Blockbuster Cliffs · $111.06B CMS Spend 9 min read
Read study
Statutory Price Transparency Study 02

Reported Wholesale Price Changes Ahead of Patent Expiration: 89 Blockbuster Drugs With California HCAI SB 17 Filings and $51.58B CMS Spend

Empirical audit of 5,355 California HCAI SB 17 Wholesale Acquisition Cost filings identifying 89 near-LOE brand drugs ($51.58B CMS spend) above the 16% statutory threshold.

89 Near-LOE Drugs · $51.58B CMS Spend 9 min read
Read study
New Drug Launch & Affordability Study 03

Specialty Drug Launch Pricing Above the Medicare Part D Threshold: California HCAI SB 17 New Drug Introduction Analysis

Analysis of 2,161 California HCAI SB 17 new drug market-introduction filings and 610 specialty therapies launching up to $285,000 introductory WAC.

610 High-Threshold Specialty Launches (2,161 Notices) 8 min read
Read study
Regulatory Exclusivity & Competition Study 04

Orphan and Biologic Exclusivity Stacking: Why High-Spend Drugs Delay Generic and Biosimilar Entry Past Primary Patent Expiration

Empirical study of 367 BLA biologics ($70.88B CMS spend), serial 7-year Orphan Drug Exclusivities, and 14 off-patent single-source brand NDAs.

$70.88B BLA Spend (0 AB Generics) · 14 Single-Source Off-Patent NDAs 9 min read
Read study